IL6 and hepatocellular carcinoma: Consistently, blocking NETs by inhibitor DNase I or using PAD4−/− mice ameliorated the inflammatory environment with persistently reduced IL‐6 levels and the development of HCC, indicating that the contribution of NETs to the initiation of inflammation favors the development of HCC.